Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must have received at least one teplizumab infusion in the 6 weeks before joining the study.
- You must have been officially diagnosed with Stage 2 type 1 diabetes by your doctor at the time of your first teplizumab infusion (note: if your condition has since progressed to Stage 3 by week 6, you may still be eligible — confirm with trial site).
- You (or your parent/legal guardian, if applicable) must be willing and able to sign a consent form agreeing to take part in the study.
Who may not be able to join:
- You have taken part in a previous clinical trial specifically testing teplizumab.
- You have been enrolled in any other clinical trial within the past 6 months (note: participation in observational studies, where no treatment is being tested, may still be allowed — confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 800-633-1610
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time from teplizumab infusion start to the onset of Stage 3 T1D
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.